GlassScriptPhysician profile
Jose Rodriguez
NPI 1912929456
$3,810.74
in general payments reported to CMS, 2019-2025
32 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $309 · 2021: $107 · 2022: $386 · 2023: $906 · 2024: $1,068 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.56 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,371.15 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $421.87 | 2019-2024 | Entyvio |
| Solventum Corporation | $183.92 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, 3m Cavilon |
| Organogenesis INC. | $155.67 | 2024-2025 | Apligraf |
| Hydrofera LLC | $135.37 | 2024 | Hydrofera Blue, Cutimed Sorbion |
| Celgene Corporation | $133.06 | 2022-2023 | Zeposia |
| Aimmune Therapeutics, INC. | $124.03 | 2024 | |
| Kci USA, INC. | $121.99 | 2023 | Activ.A.C. |
| Boston Scientific Corporation | $111.49 | 2021-2024 | Captivator II, Speedband Superview Super 7 |
| Janssen Biotech, INC. | $101.11 | 2019-2024 | Stelara, Tremfya |
| Conmed Corporation | $86.36 | 2019 | |
| Smith+Nephew, INC. | $80.42 | 2022-2023 | Regranex, Collagenase Santyl |
| Pfizer INC. | $76.38 | 2023-2025 | |
| Ardelyx, INC. | $73.07 | 2024-2025 | Ibsrela |
| Tactile Systems Technology INC | $68.51 | 2023 | Flexitouch Plus, Entre Plus |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $63.75 | 2024 | Omvoh |
| Nestle Healthcare Nutrition INC. | $63.48 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $53.91 | 2024-2025 | Voquezna |
| Olympus America INC. | $51.12 | 2020 | |
| Intercept Pharmaceuticals, INC. | $49.38 | 2019-2022 | |
| Abiomed | $41.20 | 2025 | |
| Melinta Therapeutics, LLC | $41.04 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.92 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $38.42 | 2025 | Evkeeza |
| Shire North American Group INC | $21.32 | 2019 | |
| Genzyme Corporation | $19.10 | 2024 | |
| Ucb, INC. | $17.03 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $15.63 | 2025 | Iqirvo |
| Davol INC. | $14.61 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $13.46 | 2019 | |
| Allergan, INC. | $13.31 | 2019 | |
| Reprise Biomedical, INC. | $9.66 | 2025 | Miro 3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.